Leo Mandić

Dr. Leo Mandić

Petroleum and Petrochemical Department, University of Zagreb, Faculty of Chemical Engineering and Technology, Zagreb, Zagreb, Grad, Croatia
orcid

Research Focus & Metrics

Academic Career Length

16Years (2011-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 September 2012 in Molecules
Verified
Journal Article
Open access
PDF file
KBKrešimir Benci
Krešimir Benci
Leo MandićLeo Mandić
Leo Mandić
TSTomislav Suhina
Tomislav Suhina
MSMirela Bauman Sedic
Mirela Bauman Sedic
MKMarko Klobučar
Marko Klobučar
MMMladen Mintas
Mladen Mintas
We report here on the synthesis and in vitro anti-tumor effects of a series of novel 1,2,4-triazole (compounds 3–6), 4,5-dicyanoimidazole (compound 7), and purine (compounds 8–13) coumarin derivatives and their acyclic nucleoside analogues 14–18. Structures of novel compounds 3–18 were deduced from their 1H- and 13C-NMR and corresponding mass spectra. Results of anti-proliferative assays performed on a panel of selected human tumor cell lines revealed that compound 6 had moderate cytostatic activity against the HeLa cell line (IC50 = 35 µM), whereas compound 10 showed moderate activity against the HeLa (IC50 = 33 µM), HepG2 (IC50 = 25 µM) and SW620 (IC50 = 35 µM) cell lines. These compounds showed no cytotoxic effects on normal (diploid) human fibroblasts.

1 May 2019 in Sensors and Actuators B: Chemical
Verified
Journal Article
Closed access
PBPatricia Benčić
Patricia Benčić
Leo MandićLeo Mandić
Leo Mandić
IDIva Džeba
Iva Džeba
IBIvana Tartaro Bujak
Ivana Tartaro Bujak
Laszlo BiczokLaszlo Biczok
Laszlo Biczok
NBNikola Basarić
Nikola Basarić

17 February 2016 in Medicinal Chemistry Research
Verified
Journal Article
Closed access
PDF file
KWKarlo Wittine
Karlo Wittine
IRIvana Ratkaj
Ivana Ratkaj
KBKrešimir Benci
Krešimir Benci
TSTomislav Suhina
Tomislav Suhina
Leo MandićLeo Mandić
Leo Mandić
MMMladen Mintas
Mladen Mintas

9 August 2016 in European Journal of Organic Chemistry
Verified
Journal Article
Closed access
Leo MandićLeo Mandić
Leo Mandić
KMKata Mlinarić-Majerski
Kata Mlinarić-Majerski
AGAxel G. Griesbeck
Axel G. Griesbeck
NBNikola Basarić
Nikola Basarić

1 January 2011 in Antiviral Chemistry and Chemotherapy
Verified
Journal Article
Open access
KBKrešimir Benci
Krešimir Benci
TSTomislav Suhina
Tomislav Suhina
Leo MandićLeo Mandić
Leo Mandić
Sandra Kraljević PavelićSandra Kraljević Pavelić
Sandra Kraljević Pavelić
APAndrea Tomljenović Paravić
Andrea Tomljenović Paravić
MMMladen Mintas
Mladen Mintas
Background: Several published studies indicate that the acyclic guanine nucleoside analogues possessing bis(1,2-hydroxymethyl) substituted cyclopropane rings mimicking the sugar moiety are potent inhibitors of replication of several herpes viruses. Methods: Established synthetic methods and antiviral and cytostatic activity assays were used for the evaluation of new 1,2,4-triazole and purine acyclic nucleoside analogues. Results: The synthesis of new types of acyclic nucleoside analogues which incorporate 1,2,4-triazole or purine moiety bound via flexible methylenic spacer to the bis(1,2-hydroxymethyl) cyclopropane ring. None of the new compounds showed pronounced antiviral activities at subtoxic concentrations on a broad panel of DNA and RNA viruses. Evaluation of their affinity for herpes simplex type 1 (HSV-1) and varicella-zoster virus-encoded thymidine kinases (VZV TK) also showed that none of the compounds was able to significantly inhibit 1 μM deoxythymidine phosphorylation by HSV-1 and VZV TK at 500 μM concentrations. The in vitro cytostatic activity evaluation results indicated a weak antiproliferative activity for all tested compounds. Only 6-pyrrolylpurine derivative bearing a carboxylic group substituted cyclopropane ring produced a rather slight inhibitory effect at higher micromolar concentrations on a breast carcinoma cell line (MCF-7) and no cytotoxic effect on human normal fibroblasts (WI 38). Conclusions: The lack of antiherpetic activity may be due to poor, if any, recognition of the compounds by virus-induced nucleoside kinases as an alternative substrate to become metabolically activated.

14 April 2020 in Archiv der Pharmazie
Verified
Journal Article
Closed access
PDF file
Leo MandićLeo Mandić
Leo Mandić
PBPatricia Benčić
Patricia Benčić
KMKata Mlinarić‐Majerski
Kata Mlinarić‐Majerski
SLSandra Liekens
Sandra Liekens
RSRobert Snoeck
Robert Snoeck
NBNikola Basarić
Nikola Basarić